We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.61B
1-Year Est. Return
28.28%
This Fund
S&P 500
This Quarter
Est. Return
-1.06%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$2.6B
AUM Growth
+$88.6M
(+3.5%)
Cap. Flow
+$182M
Cap. Flow
% of AUM
7%
Top 10 Holdings %
Top 10 Hldgs %
5.43%
Holding
2,448
New
367
Increased
862
Reduced
666
Closed
534
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$24.6M |
| 2 |
Viatris
VTRS
|
+$17.9M |
| 3 |
Oracle
ORCL
|
+$15.1M |
| 4 |
Cardinal Health
CAH
|
+$12.5M |
| 5 |
Lowe's Companies
LOW
|
+$11.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$10.2M |
| 2 |
Altria Group
MO
|
+$9.53M |
| 3 |
Lam Research
LRCX
|
+$8.47M |
| 4 |
Microsoft
MSFT
|
+$8.3M |
| 5 |
FedEx
FDX
|
+$8.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.78% |
| 2 | Technology | 15.81% |
| 3 | Consumer Discretionary | 13.36% |
| 4 | Industrials | 11.28% |
| 5 | Financials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Globus Medical
GMED
$11.1B
| $725K | 0.03% |
28,242
-2,564
| -8% | -$64.9K |
|
1127
Arthur J. Gallagher & Co
AJG
$63.5B
| $723K | 0.03% |
15,295
+10,870
| +246% | +$523K |
|
|
SURG
1128
DELISTED
SYNERGETICS USA, INC.
SURG
| $722K | 0.03% |
153,623
+43,886
| +40% | +$213K |
|
1129
lululemon athletica
LULU
$14B
| $721K | 0.03% |
11,036
-1,441
| -12% | -$93.7K |
|
|
CELP
1130
DELISTED
Cypress Environmental Partners, L.P.
CELP
| $719K | 0.03% |
+44,085
| New | +$691K |
|
1131
Albany International
AIN
$2.13B
| $714K | 0.03% |
17,928
+4,200
| +31% | +$169K |
|
|
CLMS
1132
DELISTED
Calamos Asset Management, Inc.
CLMS
| $712K | 0.03% |
58,112
-26,764
| -32% | -$331K |
|
|
ESPR
1133
DELISTED
Esperion Therapeutics
ESPR
| $711K | 0.03% |
+8,700
| New | +$852K |
|
|
EV
1134
DELISTED
Eaton Vance Corp.
EV
| $711K | 0.03% |
18,170
-9,938
| -35% | -$410K |
|
|
MDCO
1135
DELISTED
Medicines Co
MDCO
| $711K | 0.03% |
24,845
-76,133
| -75% | -$2.12M |
|
|
HCOM
1136
DELISTED
Hawaiian Telcom Holdco, Inc
HCOM
| $711K | 0.03% |
27,258
+7,124
| +35% | +$186K |
|
1137
Lattice Semiconductor
LSCC
$18B
| $710K | 0.03% |
120,539
-5,970
| -5% | -$37.4K |
|
1138
Northrop Grumman
NOC
$77.9B
| $710K | 0.03% |
4,475
-23,662
| -84% | -$3.79M |
|
1139
Casey's General Stores
CASY
$31.8B
| $709K | 0.03% |
+7,408
| New | +$660K |
|
|
SCX
1140
DELISTED
The L.S. Starrett Company
SCX
| $709K | 0.03% |
47,236
+17,200
| +57% | +$309K |
|
|
PERY
1141
DELISTED
Perry Ellis International Inc
PERY
| $707K | 0.03% |
29,739
-9,788
| -25% | -$242K |
|
1142
Asbury Automotive
ABG
$4.09B
| $703K | 0.03% |
7,761
-381
| -5% | -$33.1K |
|
1143
Inovio Pharmaceuticals
INO
$72M
| $703K | 0.03% |
7,183
+4,241
| +144% | +$453K |
|
|
STR
1144
DELISTED
QUESTAR CORP
STR
| $700K | 0.03% |
+33,465
| New | +$762K |
|
1145
Blackbaud
BLKB
$2.01B
| $699K | 0.03% |
12,279
+700
| +6% | +$36.6K |
|
1146
Emcor
EME
$36.1B
| $698K | 0.03% |
14,605
-11,517
| -44% | -$536K |
|
|
CBF
1147
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
| $698K | 0.03% |
24,000
+14,600
| +155% | +$416K |
|
1148
Flowers Foods
FLO
$1.53B
| $695K | 0.03% |
+32,846
| New | +$737K |
|
1149
Goldman Sachs
GS
$303B
| $695K | 0.03% |
3,329
-1,006
| -23% | -$205K |
|
|
EVRI
1150
DELISTED
Everi Holdings
EVRI
| $692K | 0.03% |
89,386
+71,630
| +403% | +$560K |
|
Similar funds
ACB
SCI
SCM
BW
HH
KCM
PRA
CC
GSA Capital Partners's Q2 2015 Portfolio in Review
As of Q2 2015, GSA Capital Partners held 2,448 positions worth $2.6B, up 3.5% from $2.52B the previous quarter. Its ten largest holdings account for 5.4% of the portfolio.
GSA Capital Partners deployed $182M of net new capital in Q2 2015, opening 367 new positions and adding to 862 existing holdings. Its largest new stake was Halliburton: 200,972 shares worth $8.66M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Illumina, an estimated $10.2M trimmed.
- GSA Capital Partners's largest Q2 2015 buy was Halliburton: 200,972 shares worth $8.66M.
- GSA Capital Partners added most to Micron Technology in Q2 2015, an estimated $24.6M increase.
- GSA Capital Partners's biggest Q2 2015 reduction was Illumina, cutting an estimated $10.2M.
- GSA Capital Partners fully exited Altria Group in Q2 2015, selling an estimated $9.53M.
- GSA Capital Partners's ten largest holdings make up 5.4% of its $2.6B portfolio in Q2 2015.
- GSA Capital Partners opened 367 new positions and closed 534 in Q2 2015.
- GSA Capital Partners's portfolio value rose 3.5% quarter-over-quarter to $2.6B.
Based on GSA Capital Partners's 13F filing for Q2 2015, filed 14 Aug 2015.